Biomet, Inc. announced that Biomet Orthopedics recently received clearance from the U.S. Food and Drug Administration to market acetabular hip liners manufactured from E-Poly™ Highly Cross linked Polyethylene. E-Poly™ liners are the world's first vitamin E stabilized highly cross linked polyethylene products to be introduced to the market. Vitamin E, a natural antioxidant, is expected to improve the longevity of the implant bearings used in total joint replacements. The E-Poly™ material was developed by combining the research of Massachusetts General Hospital.
This revolutionary technology offers multiple benefits for surgeons and patients. In laboratory testing, E-Poly™ liners have demonstrated 95-99% less wear than the existing low wear rates of Biomet's clinically successful ArCom® polyethylene liners. The E-Poly™ material also provides greater strength when compared to first generation re-melted highly crosslinked polyethylenes, while maintaining optimal oxidation resistance. In addition, E-Poly™ liners offer a technologically advanced polyethylene available for use with large diameter femoral heads, designed to provide a greater degree of joint stability.
The E-Poly™ liners will be marketed with Biomet's broad line of clinically-proven hip stems including the Taperloc® Hip System. The introduction of E-Poly™ products is a testament to Biomet's ongoing commitment to further expand our product portfolio of improved bearings, which presently includes ArCom®, ArComXL®, M2a-Taper™, M2a-Magnum™ and C2a-Taper™ technologies.
Source: Biomet
15-May-07 
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}